ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferencesView all Images (2)
Potentially life-threatening emergency
Multisystem inflammatory syndrome in children in Child
Print
Other Resources UpToDate PubMed
Potentially life-threatening emergency

Multisystem inflammatory syndrome in children in Child

Print Images (2)
Contributors: Eric Ingerowski MD, FAAP, Paritosh Prasad MD
Other Resources UpToDate PubMed

Synopsis

Although pediatric patients with primary coronavirus disease 2019 (COVID-19) usually are asymptomatic or have a very mild illness and rarely require medical attention, a new serious and potentially life-threatening syndrome associated with COVID-19 is becoming recognized and is known as multisystem inflammatory syndrome in children (MIS-C) (also known as multisystem inflammatory syndrome in children and adolescents temporally associated with COVID-19). This syndrome was first reported in the United Kingdom and has subsequently been described elsewhere in Europe, Asia, and the United States. It occurs in individuals younger than 21 years and presents with symptoms that overlap with toxic shock syndrome, Kawasaki disease, bacterial sepsis, and macrophage activation syndrome. While the etiology of this syndrome has yet to be proven, it is thought to be a postinfectious immune response to infection with the SARS-CoV-2 virus involving a possible cytokine storm. Although it is thought to be rare, the true incidence is unknown.

Patients typically present with persistent fevers, elevated inflammatory markers (increased C-reactive protein [CRP], neutrophilia, or lymphopenia), and evidence of single or multisystem end organ dysfunction. The individual features of each patient case may be variable and include a wide range of possible symptoms. Gastrointestinal symptoms including diarrhea and vomiting are common. Gastrointestinal imaging may reveal ileitis, ascites, and bowel wall thickening. Several of these patients have shown signs of shock (cardiogenic or vasogenic) with hypotension and supplemental O2 requirements and have had single or multisystem end organ dysfunction requiring admission to the intensive care unit (ICU).

Cardiac symptoms are present in over 50% of cases and include myocarditis; decreased cardiac output and features of shock; coronary artery inflammation, dilatation, or aneurysm; and pericardial effusions. Other features such as lymphadenopathy, mucous membrane changes, rash, swelling of the hands and feet, conjunctivitis, pharyngitis, headache, neck pain, and/or mental status changes may also be present. A cough is present in less than one-third of all patients.

Laboratory findings show evidence of inflammation and end organ dysfunction and frequently include abnormal fibrinogen, high D-dimers, lactic acid dehydrogenase (LDH), interleukin (IL)-6 and ferritin, elevated CRP, hypoalbuminemia, neutrophilia, and lymphopenia. Laboratory signs of acute kidney injury, coagulopathy, and transaminitis have been described as well as elevated troponin, proBNP, anemia, and thrombocytopenia.

Many of the patients have positive serologic testing for SARS-CoV-2, indicating that this is a later manifestation of COVID-19. A small minority of patients, however, have had positive reverse transcription polymerase chain reaction (RT-PCR) or antigen testing, while others were negative on all tests. Other microbiologic causes of the above symptoms as well as other diagnoses that could explain the patient's symptoms must be ruled out.

Because this is newly described syndrome, the case definition is likely still evolving. On May 14, 2020, the US Centers for Disease Control and Prevention (CDC) published its case definition (see Look For).

Codes

ICD10CM:
U07.1 – COVID-19

SNOMEDCT:
840539006 – Disease caused by severe acute respiratory syndrome coronavirus 2

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed: 06/03/2020
Last Updated: 06/19/2020
Copyright © 2020 VisualDx®. All rights reserved.
Potentially life-threatening emergency
Multisystem inflammatory syndrome in children in Child
Print 2 Images
View all Images (2)
(with subscription)
Multisystem inflammatory syndrome in children : Abdominal pain, Patient appears ill
Copyright © 2020 VisualDx®. All rights reserved.